This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nollau, P. Articles by Neumaier, M. Search for Related Content PubMed PubMed Citation Articles by Nollau, P. Articles by Neumaier, M.

American Journal of Pathology, Vol 151, 521-530, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

Dysregulation of carcinoembryonic antigen group members CGM2, CD66a (biliary glycoprotein), and nonspecific cross-reacting antigen in colorectal carcinomas. Comparative analysis by northern blot and in situ hybridization

P Nollau, F Prall, U Helmchen, C Wagener and M Neumaier
Abteilung fur Klinische Chemie, Universitatskrankenhaus Eppendorf, Hamburg, Germany.

Genes coding for CD66a (biliary glycoprotein), carcinoembryonic antigen (CEA) group member 2 (CGM2), and nonspecific cross-reacting antigen (NCA) are members of the human CEA gene subgroup. We investigated a series of 11 colorectal carcinomas by Northern blot and isotopic in situ hybridization (ISH), demonstrating underexpression of CD66a and CGM2 in the majority of the carcinomas as compared with the normal mucosa, whereas NCA was overexpressed. ISH for CD66a and CGM2 mRNA revealed that large areas of the carcinomas remained without or with only faint hybridization signals. However, in every carcinoma, at least some positive foci were observed, indicating remaining cell populations that actively transcribe CD66a and CGM2. In contrast, ISH for NCA displayed strong and extensive autoradiographic signals. By analysis of step sections, foci of CD66a and CGM2 expression were shown to co- localize. Furthermore, these foci contained relatively few nuclei immunohistochemically positive for the proliferation-associated nuclear antigen Ki-67. Our data indicate a dysregulation of the three genes possibly with a common transcriptional control for CD66a and CGM2 and a different control for NCA. The focal expression of CD66a and CGM2 could be interpreted as due to a focal, incomplete, and abortive differentiation or, alternatively, as a consequence of genetic heterogeneity with foci of slow-proliferating subclones.

This article has been cited by other articles:

				N. Kilic, L. Oliveira-Ferrer, S. Neshat-Vahid, S. Irmak, K. Obst-Pernberg, J.-H. Wurmbach, S. Loges, E. Kilic, J. Weil, H. Lauke, et al. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1 Blood, December 15, 2007; 110(13): 4223 - 4233. [Abstract] [Full Text] [PDF]

				R. N. Samara, L. M. Laguinge, and J. M. Jessup Carcinoembryonic Antigen Inhibits Anoikis in Colorectal Carcinoma Cells by Interfering with Trail-R2 (DR5) Signaling Cancer Res., May 15, 2007; 67(10): 4774 - 4782. [Abstract] [Full Text] [PDF]

				A.-M. Bamberger, J. Briese, J. Gotze, I. Erdmann, H. M. Schulte, C. Wagener, and P. Nollau Stimulation of CEACAM1 expression by 12-O-tetradecanoylphorbol-13-acetate (TPA) and calcium ionophore A23187 in endometrial carcinoma cells Carcinogenesis, March 1, 2006; 27(3): 483 - 490. [Abstract] [Full Text] [PDF]

				K. P.J.M. van Gisbergen, C. A. Aarnoudse, G. A. Meijer, T. B.H. Geijtenbeek, and Y. van Kooyk Dendritic Cells Recognize Tumor-Specific Glycosylation of Carcinoembryonic Antigen on Colorectal Cancer Cells through Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Nonintegrin Cancer Res., July 1, 2005; 65(13): 5935 - 5944. [Abstract] [Full Text] [PDF]

				N. Kilic, L. Oliveira-Ferrer, J.-H. Wurmbach, S. Loges, F. Chalajour, S. N. Vahid, J. Weil, M. Fernando, and S. Ergun Pro-angiogenic Signaling by the Endothelial Presence of CEACAM1 J. Biol. Chem., January 21, 2005; 280(3): 2361 - 2369. [Abstract] [Full Text] [PDF]

				L. Oliveira-Ferrer, D. Tilki, G. Ziegeler, J. Hauschild, S. Loges, S. Irmak, E. Kilic, H. Huland, M. Friedrich, and S. Ergun Dual Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Angiogenesis and Invasion of Human Urinary Bladder Cancer Cancer Res., December 15, 2004; 64(24): 8932 - 8938. [Abstract] [Full Text] [PDF]

				O. Volpert, W. Luo, T.-J. Liu, V. T. Estrera, C. Logothetis, and S.-H. Lin Inhibition of Prostate Tumor Angiogenesis by the Tumor Suppressor CEACAM1 J. Biol. Chem., September 13, 2002; 277(38): 35696 - 35702. [Abstract] [Full Text] [PDF]

				A. Nakajima, H. Iijima, M. F. Neurath, T. Nagaishi, E. E. S. Nieuwenhuis, R. Raychowdhury, J. Glickman, D. M. Blau, S. Russell, K. V. Holmes, et al. Activation-Induced Expression of Carcinoembryonic Antigen-Cell Adhesion Molecule 1 Regulates Mouse T Lymphocyte Function J. Immunol., February 1, 2002; 168(3): 1028 - 1035. [Abstract] [Full Text] [PDF]

				K. M. Skubitz, K. D. Campbell, and A. P. N. Skubitz Synthetic Peptides of CD66a Stimulate Neutrophil Adhesion to Endothelial Cells J. Immunol., April 15, 2000; 164(8): 4257 - 4264. [Abstract] [Full Text] [PDF]

				V. T. Estrera, D.-T. Chen, W. Luo, D. C. Hixson, and S.-H. Lin Signal Transduction by the CEACAM1 Tumor Suppressor. PHOSPHORYLATION OF SERINE 503 IS REQUIRED FOR GROWTH-INHIBITORY ACTIVITY J. Biol. Chem., April 27, 2001; 276(18): 15547 - 15553. [Abstract] [Full Text] [PDF]